Strand Therapeutics: Funding, Investors & Team (Sep 2026)
Strand Therapeutics is a company that uses a biotechnology platform to develop gene therapies with the help of synthetic biology. Their products include immunotherapies that assist cells in producing specific cancer-fighting proteins, leading to improved immune system response in cancer patients.
Strand Therapeutics has raised $153M across 1 funding round on record, the most recent a Series B of $153M announced in Aug 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Strand Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2025.
Strand Therapeutics Funding Rounds
Strand Therapeutics Founders and Leadership Team
Contact details for the Strand Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Strand Therapeutics Funding Compared to Other Biotechnology Startups
Strand Therapeutics' latest round of $153M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Strand Therapeutics in Biotechnology and Cambridge
Companies Similar to Strand Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Strand Therapeutics Funding FAQs
What does Strand Therapeutics do?
Strand Therapeutics is a company that uses a biotechnology platform to develop gene therapies with the help of synthetic biology. Their products include immunotherapies that assist cells in producing specific cancer-fighting proteins, leading to improved immune system response in cancer patients.
How much funding has Strand Therapeutics raised?
Strand Therapeutics has raised $153M across 1 round on record. The most recent is a Series B of $153M announced in Aug 2025.
When did Strand Therapeutics last raise funding?
Strand Therapeutics' most recent funding round on record is a Series B of $153M, announced in Aug 2025.
Who founded Strand Therapeutics?
FundedIQ lists Ron Weiss (Founder) at Strand Therapeutics.
Where is Strand Therapeutics headquartered?
Strand Therapeutics is based in Cambridge, Massachusetts, United States.
How many employees does Strand Therapeutics have?
Strand Therapeutics is in the 101-250 employee band.
How does Strand Therapeutics' funding compare to other Biotechnology startups?
Strand Therapeutics' latest round of $153M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Strand Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Strand Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.